Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by progressive ataxia beginning during childhood, deafness and intellectual deficit.
Features include: Progressive sensorineural hearing impairment, Ataxia, and Intellectual disability.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Ataxia, Intellectual disability |
Ears | 1 | Progressive sensorineural hearing impairment |
Biomarker and diagnostic research for ataxia - deafness - intellectual disability syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ataxia - deafness - intellectual disability syndrome.
131 publications have been identified in PubMed for ataxia - deafness - intellectual disability syndrome. Research spans Review / Meta-Analysis (66%), Basic Science / Preclinical (14%), and Case Report / Case Series (8%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 87 | 66% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
18 |
14% |
Patient case studies | 10 | 8% |
Disease patterns and progression | 8 | 6% |
Other research | 4 | 3% |
Testing and diagnosis research | 3 | 2% |
Clinical study results | 1 | 1% |
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Ahmad N (2026). [PMID: 41525964](https://pubmed.ncbi.nlm.nih.gov/41525964/). *Clin Chim Acta*. [Case Report / Case Series]
Shokouhian E (2026). [PMID: 39847269](https://pubmed.ncbi.nlm.nih.gov/39847269/). *J Appl Genet*. [Review / Meta-Analysis]
Shakeri S (2026). [PMID: 41724667](https://pubmed.ncbi.nlm.nih.gov/41724667/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Karuntu JS (2025). [PMID: 39733931](https://pubmed.ncbi.nlm.nih.gov/39733931/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Yacoub MR (2025). [PMID: 40747632](https://pubmed.ncbi.nlm.nih.gov/40747632/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]
Pena C (2025). [PMID: 40146047](https://pubmed.ncbi.nlm.nih.gov/40146047/). *Minerva Med*. [Review / Meta-Analysis]
Walther LE (2025). [PMID: 40192781](https://pubmed.ncbi.nlm.nih.gov/40192781/). *HNO*. [Review / Meta-Analysis]